Abstract
Abstract Background: selenium forms components of seleno-protein in the body. Seleno-methionine integrated into proteins instead of methionine and acts as a storage pool. The active form of selenium in proteins is seleno-cysteine. This article aims to know the results of selenium effects on thyroid status in recent clinical trials. The systemic review seeks to find out the correlation between the supplementation of selenium and anti-TPO antibodies and T4 levels in Hashimoto thyroiditis. Selenium supplementation decreases the level of anti-TPO antibodies. The supplementation of selenium increases the level of T4 standards. Methods: the mean and standard deviation (SD) of all eight studies calculated, One of the researches had all the information in figures, and only the levels of anti-TPO antibodies and FT4 obtained. Heterogeneity was estimated using I2. Results: the p-value calculated for anti-TPO by SPSS of the eight groups had a p-value of 0.142. The p-value calculated for T4 levels by SPSS of the five groups had a p-value of 0.239. The heterogeneity test was zero after the 12 tests. The studies included in the systematic review assessed by Prisma diagram and selected among articles resulted from search keywords selenium and anti- TPO and Hashimotos Thyroiditis on different data sources all the participants were evaluated by sex, ages, duration of the study and the levels of anti-TPO Ab and thyroxin (T4) and then using SPSS software to deploy meta-analysis in the systematic review. Conclusion: in 6 of 8 studies, it was a relationship between selenium and thyroid status, whereas two studies were not. As the authors run analysis on the data, they realized that there is no significant desired effect from selenium on Thyroid antibodies against the previous researchs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There is no external funding received.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is on the last page of file dhown in a table.
